Genaera ends Lomucin, squalamine trials

GENR discontinued studies of Lomucin talniflumate for cystic fibrosis and squalamine lactate to treat prostate cancer. The decision to end the

Read the full 211 word article

How to gain access

Continue reading with a
two-week free trial.